Biomarkers for kidney transplant rejection

Area of Science:

• Immunology
• Transplantation Medicine
• Biomarker Discovery

Background:

• Current organ transplant immune management lacks objective tools for assessing alloimmune status.
• Prognostic imprecision contributes to patient morbidity and reduced allograft survival.
• Existing diagnostic methods for rejection or infection are limited.

Purpose of the Study:

• To review the characteristics of biomarkers and surrogate end points in transplantation.
• To discuss current biomarkers under clinical investigation for organ rejection.
• To identify barriers hindering the clinical translation of these biomarkers.

Main Methods:

• Review of current literature on biomarkers in organ transplantation.
• Analysis of candidate biomarkers for predicting rejection and immune capacity.
• Discussion of challenges in biomarker validation and clinical implementation.

Main Results:

• Numerous candidate biomarkers for organ rejection exist but lack robust validation.
• No noninvasive biomarker currently guides clinical practice independently of traditional methods.
• Significant barriers impede the translation of promising biomarkers into routine care.

Conclusions:

• Noninvasive biomarkers are needed to individualize immunosuppression and enable early intervention in transplant recipients.
• Further validation studies are essential to confirm the clinical utility of candidate biomarkers.
• Overcoming translational barriers is critical for improving patient outcomes and allograft survival.